Filtered By:
Source: Journal of Stroke and Cerebrovascular Diseases
Condition: Atrial Fibrillation
This page shows you your search results in order of relevance. This is page number 8.
Order by Relevance | Date
Total 320 results found since Jan 2013.
Paroxysmal Atrial Fibrillation in Cryptogenic Stroke: A Case–Control Study
Conclusions: Very short episodes of PAF are common in patients with CS and with SKC, but their pathogenic significance is unclear. Predominance of PAF in younger patients with CS and embolic infarct pattern suggests a causative role in these cases. More research is needed before prolonged cardiac rhythm monitoring can be recommended to guide anticoagulation in CS patients.
Source: Journal of Stroke and Cerebrovascular Diseases - June 21, 2013 Category: Neurology Authors: Alejandro A. Rabinstein, Jennifer E. Fugate, Jay Mandrekar, Joseph D. Burns, Raymond C.S. Seet, Stefan A. Dupont, Timothy J. Kauffman, Samuel J. Asirvatham, Paul A. Friedman Tags: Original Articles Source Type: research
Predictors of In-hospital Mortality and the Risk of Symptomatic Intracerebral Hemorrhage after Thrombolytic Therapy with Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke
This study aimed to determine the independent predictors of in-hospital mortality (IHM) and the risk of sICH after rt-PA therapy. A total of 1007 patients (mean age, 72 ± 12 years; 52% women; mean National Institutes of Health Stroke Scale [NIHSS] score, 11.6 ± 5.6) with AIS treated with rt-PA were enrolled in this study during a 42-month period beginning in November 2007. Univariate and multivariate regression analyses were performed to estimate the predictors of IHM. Eighty-three of the 1007 patients (8.2%) died during hospitalization (mean duration of hospitalization, 10 ± 1.8 days). Logistic regression estimated the...
Source: Journal of Stroke and Cerebrovascular Diseases - May 14, 2012 Category: Neurology Authors: Mohamed Al-Khaled, Christine Matthis, Jürgen Eggers Tags: Original Articles Source Type: research
Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in a Stroke Patient Treated with Rivaroxaban
As limited amounts of data are available regarding thrombolytic therapy for patients taking novel oral anticoagulants, thrombolytic therapy is not recommended in such cases. Here, we report an acute stroke patient taking rivaroxaban who received intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA). An 80-year-old man with a history of nonvalvular atrial fibrillation, who had been receiving 10 mg of rivaroxaban showed abrupt onset of aphasia and right hemiparesis. National Institutes of Health Stroke Scale score was 10.
Source: Journal of Stroke and Cerebrovascular Diseases - September 30, 2014 Category: Neurology Authors: Hideyuki Ishihara, Hiroaki Torii, Hirochika Imoto, Fumiaki Oka, Hirokazu Sadahiro, Michiyasu Suzuki Tags: Case Report Source Type: research
Association of Plasma Brain Natriuretic Peptide Levels in Acute Ischemic Stroke Subtypes and Outcome
Brain natriuretic peptide (BNP) is believed to be a diagnostic marker for cardiovascular diseases, including atrial fibrillation (AF). Recent studies have incriminated BNP as a marker of cardioembolic stroke. We aimed at investigating association of plasma BNP levels in acute ischemic stroke subtypes and their outcome in Indian patients.
Source: Journal of Stroke and Cerebrovascular Diseases - December 15, 2014 Category: Neurology Authors: Jaydip Ray Chaudhuri, Vijay Kumar Sharma, Kandadai Rukmini Mridula, Banda Balaraju, Venkata Chandra Sekher Srinivasarao Bandaru Source Type: research
Anticoagulant Treatment in Patients with Atrial Fibrillation and Ischemic Stroke
Atrial fibrillation (AF) is the most common cardiac dysrhythmia, with a lifetime risk of 25%, and it is a well-known independent risk factor for ischemic stroke. Over the last 15 years, efforts have been made to initiate relevant treatment in patients with AF. A retrospective study was set up to clarify whether this effort has resulted in a decreased proportion of patients with known AF experiencing an ischemic stroke.
Source: Journal of Stroke and Cerebrovascular Diseases - April 13, 2015 Category: Neurology Authors: Nicole Scheldon Brunner Frandsen, Andreas Dammann Andersen, Hamoun Ashournia, Ivan Brandslund, Jens Ole Kjærsgaard, Ole Jakob Vilholm Source Type: research
Early Stroke Risk after Transient Ischemic Attack in Patients Without Large-Artery Disease or Atrial Fibrillation
Patients with transient ischemic attack (TIA) without large-artery disease (LAD) or atrial fibrillation (AF) on admission may be at higher risk of stroke than previously thought. The aim of this study was to investigate early stroke risk and its predictors in such patients.
Source: Journal of Stroke and Cerebrovascular Diseases - April 23, 2015 Category: Neurology Authors: Tomoyuki Ohara, Toshiyuki Uehara, Kazunori Toyoda, Rieko Suzuki, Shoichiro Sato, Kazuyuki Nagatsuka, Kazuo Minematsu Source Type: research
Atrial Fibrillation and Stroke: It's About Point of View
In this issue of the journal, Frandsen et al report that the proportion of atrial fibrillation (AF)-associated ischemic strokes has not changed over 15 years (1997-2012) among all ischemic strokes in patients admitted to a Danish hospital.1 The finding may seem surprising because of the proven efficacy of oral anticoagulants for stroke prevention in patients with AF and the substantial world-wide diffusion effort during this interval. Indeed, the authors also found that the rate of prestroke use of oral anticoagulants (ie, in “treatment failures” in their stroke database) rose over the years in their patients suggest...
Source: Journal of Stroke and Cerebrovascular Diseases - April 30, 2015 Category: Neurology Authors: David C. Anderson, Richard W. Asinger Tags: Editorial Source Type: research
Detection and Predictors of Paroxysmal Atrial Fibrillation in Acute Ischemic Stroke and Transient Ischemic Attack Patients in Singapore
Detection of paroxysmal atrial fibrillation (pAF) is important for optimal secondary stroke prevention. Data are limited from Asia regarding inpatient occurrence and predictors of pAF to optimize electrocardiographic (ECG) monitoring despite it having nearly two thirds of the world's population and different subtypes of stroke from the West.
Source: Journal of Stroke and Cerebrovascular Diseases - June 24, 2015 Category: Neurology Authors: Sze Haur Lee, Yan Sun Source Type: research
A Score for Predicting Paroxysmal Atrial Fibrillation in Acute Stroke Patients: iPAB Score
Detection of paroxysmal atrial fibrillation (PAF) after a stroke is challenging. The purpose of this study was to develop a clinical score to predict PAF in a cohort of acute ischemic stroke patients prospectively and to validate it in an independent cohort.
Source: Journal of Stroke and Cerebrovascular Diseases - July 16, 2015 Category: Neurology Authors: Kotaro Yoshioka, Kosuke Watanabe, Satoshi Zeniya, Yoko Ito, Masaki Hizume, Toshiro Kanazawa, Makoto Tomita, Satoru Ishibashi, Hirotomo Miake, Hiroaki Tanaka, Takanori Yokota, Hidehiro Mizusawa Source Type: research
HRS/NSA 2014 Survey of Atrial Fibrillation and Stroke: Gaps in Knowledge and Perspective, Opportunities for Improvement
The prevalence of atrial fibrillation (AF) is substantial and increasing. Stroke is common in AF and can have devastating consequences. Oral anticoagulants are effective in reducing stroke risk, but are underutilized.
Source: Journal of Stroke and Cerebrovascular Diseases - August 1, 2015 Category: Neurology Authors: David S. Frankel, Sarah E. Parker, Lynda E. Rosenfeld, Philip B. Gorelick Tags: Review Article Source Type: research
Impact of Sex Difference on Severity and Functional Outcome in Patients with Cardioembolic Stroke
Female sex is a risk factor for thromboembolic events in Caucasian, but not in Japanese, patients with nonvalvular atrial fibrillation. However, it remains unclear whether the female sex is also a risk factor for severe stroke and unfavorable functional outcome in patients with cardioembolic (CE) stroke.
Source: Journal of Stroke and Cerebrovascular Diseases - September 2, 2015 Category: Neurology Authors: Hirofumi Tomita, Joji Hagii, Norifumi Metoki, Shin Saito, Hiroshi Shiroto, Hiroyasu Hitomi, Takaatsu Kamada, Satoshi Seino, Koki Takahashi, Yoshiko Baba, Satoko Sasaki, Takamitsu Uchizawa, Manabu Iwata, Shigeo Matsumoto, Yoshihiro Shoji, Tomohiro Tanno, T Source Type: research
Atrial Cardiopathy and Cryptogenic Stroke: A Cross-sectional Pilot Study
There is increasing evidence that left atrial dysfunction or cardiopathy is associated with ischemic stroke risk independently of atrial fibrillation. We aimed to determine the prevalence of atrial cardiopathy biomarkers in patients with cryptogenic stroke.
Source: Journal of Stroke and Cerebrovascular Diseases - October 14, 2015 Category: Neurology Authors: Shadi Yaghi, Amelia K. Boehme, Rebecca Hazan, Eldad A. Hod, Alberto Canaan, Howard F. Andrews, Hooman Kamel, Randolph S. Marshall, Mitchell S.V. Elkind Source Type: research
Design and Rationale of the RELAXED (Recurrent Embolism Lessened by rivaroxaban, an Anti-Xa agent, of Early Dosing for acute ischemic stroke and transient ischemic attack with atrial fibrillation) Study
In the acute phase of cardioembolic stroke in patients with nonvalvular atrial fibrillation (NVAF), the recurrence rate is high. Nonvitamin K antagonist oral anticoagulants may be appropriate for prevention of early recurrence because they have a much lower risk of hemorrhagic stroke than warfarin.
Source: Journal of Stroke and Cerebrovascular Diseases - March 14, 2016 Category: Neurology Authors: Masahiro Yasaka, Kazuo Minematsu, Kazunori Toyoda, Hiroshi Yamagami, Shinichi Yoshimura, Takehiko Nagao, Etsuro Mori, Teruyuki Hirano, Toshimitsu Hamasaki, Takenori Yamaguchi Source Type: research
The Influence of Left Atrial Enlargement on the Relationship between Atrial Fibrillation and Stroke
Left atrial enlargement (LAE) is independently associated with an increased risk of stroke and atrial fibrillation (AF). The combination of both LAE and AF possibly increases the risk of stroke beyond that observed with AF.
Source: Journal of Stroke and Cerebrovascular Diseases - March 21, 2016 Category: Neurology Authors: Stephen T. Broughton, Wesley T. O'Neal, Taufiq Salahuddin, Elsayed Z. Soliman Source Type: research
Visual Aid Tool to Improve Decision Making in Anticoagulation for Stroke Prevention
The management of stroke prevention among patients with atrial fibrillation (AF) has changed in the last few years. Despite the benefits of new oral anticoagulants (NOACs), decisions about the optimal agent remain a challenge. We provide a visual aid tool to guide clinicians and patients in the decision process of selecting oral anticoagulants for stroke prevention.
Source: Journal of Stroke and Cerebrovascular Diseases - June 14, 2016 Category: Neurology Authors: Gustavo Saposnik, Raed A. Joundi Source Type: research
